PACIRA BIOSCIENCES INC (PCRX) Institutional Ownership Changes & 13F Activity
PACIRA BIOSCIENCES INC (PCRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Citadel Advisors Llc, Invesco Ltd., Two Sigma Investments, Lp, Millennium Management Llc, and Jefferies Financial Group Inc..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Integrated Wealth Concepts Llc | Buy | +3,482 | +8.6% | 43,764 | $1.11M | Q2 2026 | Sep 09, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -640 | -5.8% | 10,350 | $262.58K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -635,117 | -79.7% | 162,164 | $4.11M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -1,315 | -2.1% | 59,991 | $1.52M | Q2 2026 | Aug 24, 2026 |
| Assenagon Asset Management S.A. | Buy | +101,429 | — | 101,429 | $2.57M | Q2 2026 | Aug 21, 2026 |
| Fulcrum Asset Management Llp | Buy | +54 | — | 54 | $1.35K | Q2 2026 | Aug 18, 2026 |
| Jefferies Financial Group Inc. | Buy | +173,800 | +88.5% | 370,092 | $9.39M | Q2 2026 | Aug 17, 2026 |
| Empowered Funds, Llc | Sell | -76,703 | -27.7% | 200,073 | $5.08M | Q2 2026 | Aug 17, 2026 |
| Public Employees Retirement System Of Ohio | Buy | +3,845 | +10.2% | 41,385 | $1.05M | Q2 2026 | Aug 17, 2026 |
| Caitlin John, Llc | Buy | +337 | +7.7% | 4,721 | $119.77K | Q2 2026 | Aug 17, 2026 |
| Invesco Ltd. | Buy | +249,350 | — | 249,350 | $6.33M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +197,753 | +37.5% | 724,604 | $18.38M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +178,132 | +312.3% | 235,163 | $5.97M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +163,096 | — | 163,096 | $4.14M | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Buy | +125,370 | — | 125,370 | $3.18M | Q2 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Buy | +85,075 | +17.8% | 563,458 | $14.29M | Q2 2026 | Aug 14, 2026 |
| J. Goldman & Co Lp | Sell | -75,694 | -77.4% | 22,078 | $560.12K | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +60,963 | — | 60,963 | $1.55M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +51,569 | +27.4% | 240,006 | $6.09M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -50,589 | -55.5% | 40,525 | $1.03M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +47,543 | +258.6% | 65,927 | $1.67M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -42,787 | -2.7% | 1,527,129 | $38.74M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Sell | -41,256 | -5.6% | 690,786 | $17.53M | Q2 2026 | Aug 14, 2026 |
| Freestone Grove Partners Lp | Sell | -36,417 | -100.0% | 5 | $127.00 | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Sell | -32,392 | -1.6% | 1,950,332 | $49.48M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +28,081 | +10.0% | 310,189 | $7.87M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -22,119 | -67.7% | 10,566 | $268.06K | Q2 2026 | Aug 14, 2026 |
| Varcov Co. | Buy | +21,650 | — | 21,650 | $549.26K | Q2 2026 | Aug 14, 2026 |
| Caxton Associates Llp | Buy | +21,604 | +61.2% | 56,917 | $1.44M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -21,339 | -60.1% | 14,144 | $358.83K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about PCRX activity
Which institutional owners are buying PCRX?
Institutional owners buying PCRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in PCRX activity?
"Buy" means an investor increased their reported position in PCRX compared to the prior reporting period. This reflects growing exposure to PACIRA BIOSCIENCES INC (PCRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in PCRX increasing?
Institutional interest in PCRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related PCRX Institutional Insights
- PCRX Overview
- PCRX 13F Institutional Holders
- PCRX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- PCRX Insider Trading & SEC Form 4 Activity
- PCRX Articles
- Top Institutional Investor Stock Rankings